Rankings
▼
Calendar
PASG Q4 2025 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena
PASG
Passage Bio, Inc.
$29M
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$200,000
Operating Income
-$14M
Net Income
-$13M
EPS (Diluted)
$-3.98
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$609,000
Balance Sheet
Total Assets
$62M
Total Liabilities
$44M
Stockholders' Equity
$19M
Cash & Equivalents
$46M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$200,000
-$719,000
+127.8%
Operating Income
-$14M
-$14M
+3.0%
Net Income
-$13M
-$13M
-2.0%
← FY 2025
All Quarters